Gufic BioSciences Ltd
₹283.05
(0.37%)
Tue, 10 Mar 2026, 05:28 pm
Health Technology
Pharmaceuticals: Major
24.5KGufic BioSciences Share Price Live Chart
1 Day
0 (0%)
No Result Found
Summary
Market Cap
2776.32
Net Profit
69.65
P/B
5.61
Sector P/E
32.42
P/E
48.41
EV/EBITDA
26.34
Debt/Equity (Industry)
0.23
Interest Cover (Industry)
10.03
ROCE (Industry)
12.82
RONW (Industry)
12.23
ROE
12.29
ROCE
12.86
Debt/Equity
0.59
EPS (TTM)
4.99
Dividend Yield
0.04
Book Value
62.94
Interest Cover
4.84
Analysis
all
- Gufic Biosciences is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Gufic Biosciences is profitable, therefore cash runway is not a concern.
- Gufic Biosciences is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (24.3%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 2.3x debt.
- Gufic Biosciences is not paying a notable dividend for India, therefore no need to check if the payments are increasing.
- No need to calculate the sustainability of Gufic Biosciences's dividends as it is not paying a notable one for India.
- Gufic Biosciences is not paying a notable dividend for India, therefore no need to check if the payments are stable.
- Gufic Biosciences's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Gufic Biosciences's dividend is below the markets top 25% of dividend payers in India (3.08%).
Shareholding
| Shareholders | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 | DEC 2024 |
|---|---|---|---|---|---|
| Promoters | 72.50 | 72.50 | 72.51 | 72.51 | 72.51 |
| FII | 0.44 | 0.34 | 0.32 | 0.31 | 0.30 |
| DII | 3.74 | 3.65 | 3.38 | 3.39 | 2.98 |
| Public | 23.32 | 23.51 | 23.80 | 23.79 | 24.20 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 387.80 | 340.45 | 311.75 | 293.10 | 264.40 | 245.75 | 198.40 |
| Fibonacci | 340.45 | 322.36 | 311.19 | 293.10 | 275.01 | 263.84 | 245.75 |
| Camarilla | 296.07 | 291.73 | 287.39 | 293.10 | 278.71 | 274.37 | 270.03 |
Pivots Level: Classic
R3
+94.70
387.80
R2
+47.35
340.45
R1
+18.65
311.75
S1
-28.70
264.40
S2
-47.35
245.75
S3
-94.70
198.40
Moving Average
Period
Value
10-EMA
282.77
20-EMA
288.33
30-EMA
294.05
50-EMA
303.72
100-EMA
320.01
200-EMA
337.77
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 13 Feb 2026 | board-meetings | Quarterly Results, Nine Months Results | |
| 14 Nov 2025 | board-meetings | Quarterly Results | |
| 10 Sept 2025 | agm | ||
| 22 Aug 2025 | dividend | Final Dividend - Rs. - 0.1 | 22 Sept 2025 |
| 30 May 2025 | dividend | ₹0.10 Dividend /Share | 22 Sept 2025 |
| 04 Sept 2024 | agm | ||
| 17 Aug 2024 | dividend | Annual General Meetingdividend - Re 0.10 Per Share | 19 Sept 2024 |
| 29 May 2024 | dividend | ₹0.10 Dividend /Share | 19 Sept 2024 |
| 01 Sept 2023 | agm | ||
| 21 Aug 2023 | dividend | Annual General Meeting/Dividend - Re 0.10 Per Share | 22 Sept 2023 |
Peer Comparison
Gufic BioSciences Ltd
Divis Laboratories Ltd
Cipla Ltd
Dr Reddys Laboratories Ltd
Torrent Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Gufic BioSciences Ltd About
Gufic BioSciences principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1984
Headquarters
CEO
Jayesh P Choksi
Employees
Contact
Website
http://www.gufic.com
corporaterelations@guficbio.com; mgr_legal@guficbi
Phone
91-022-66919187/67261007/66919189
Location
Shop-37 1st Flr Kamala Bhavan, Swami Nityanand Road Andheri(E, Mumbai, Maharashtra, 400069
Gufic BioSciences Ltd Company History
| Year | History |
|---|---|
| 2007 |
|
| 2008 |
|
| 2012 |
|
| 2013 |
|
| 2014 |
|
Deals
| Client Name | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|
| GRAVITON RESEARCH CAPITAL LLP | Sell | 587787 | 329.72 | 30 Nov 2023 |
| GRAVITON RESEARCH CAPITAL LLP | Buy | 587787 | 329.69 | 30 Nov 2023 |
| FINANCIAL INVESTORS TRUST A/C GRANDEUR PEAK GLOBAL OPPORTUNITIES FUND | Buy | 500000 | 205.89 | 12 Aug 2021 |
| GRAVITON RESEARCH CAPITAL LLP | Sell | 460125 | 189.94 | 12 May 2021 |
| GRAVITON RESEARCH CAPITAL LLP | Buy | 460125 | 190.06 | 12 May 2021 |
| SBI MUTUAL FUND | Buy | 2170000 | 60.1 | 18 May 2017 |
| GKN SECURITIES | Buy | 480568 | 73.92 | 18 May 2017 |
| SAMBHAV PROPERTIES LLP | Sell | 7100000 | 60.14 | 18 May 2017 |
| PARTH INFIN BROKERS PVT. LTD. | Buy | 1391309 | 72.67 | 18 May 2017 |
| SBI MUTUAL FUND | Buy | 3200000 | 60.1 | 18 May 2017 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800